A citation-based method for searching scientific literature

Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
717
66


COVID-19's Impact on Genetics at One Medical Center in New York.
Elaine M Pereira, Wendy K Chung. Genet Med 2020
9
33

Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic.
Jonathan M Marron, Steven Joffe, Reshma Jagsi, Rebecca A Spence, Fay J Hlubocky. J Clin Oncol 2020
66
33

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
Humaid O Al-Shamsi, Waleed Alhazzani, Ahmad Alhuraiji, Eric A Coomes, Roy F Chemaly, Meshari Almuhanna, Robert A Wolff, Nuhad K Ibrahim, Melvin L K Chua, Sebastien J Hotte,[...]. Oncologist 2020
265
33


Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.
Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
55
33

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
Aryana S Jacobs, Marc D Schwartz, Heiddis Valdimarsdottir, Rachel H Nusbaum, Gillian W Hooker, Tiffani A DeMarco, Jessica E Heinzmann, Wendy McKinnon, Shelley R McCormick, Claire Davis,[...]. Fam Cancer 2016
13
33

Transitioning to a New Normal in the Post-COVID Era.
Di M Jiang, Alejandro Berlin, Lesley Moody, Rajat Kumar, Breffni Hannon, Monika K Krzyzanowska, Neesha Dhani, Heather Cole, Mary Elliott, Srikala S Sridhar. Curr Oncol Rep 2020
4
33

Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.
Eva Segelov, Craig Underhill, Hans Prenen, Christos Karapetis, Christopher Jackson, Louise Nott, Tim Clay, Nick Pavlakis, Sabe Sabesan, Ellen Heywood,[...]. JCO Oncol Pract 2020
27
33


Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy.
Nicola Brunetti-Pierri, Simona Fecarotta, Annamaria Staiano, Pietro Strisciuglio, Giancarlo Parenti. Genet Med 2020
8
33

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
29
33

Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist.
Priya Bansal, Theresa A Bingemann, Matthew Greenhawt, Giselle Mosnaim, Anil Nanda, John Oppenheimer, Hemant Sharma, David Stukus, Marcus Shaker. J Allergy Clin Immunol Pract 2020
61
33

Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.
Stephanie A Cohen, Monica L Marvin, Bronson D Riley, Hetal S Vig, Julie A Rousseau, Shanna L Gustafson. J Genet Couns 2013
74
33

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.
Jeanna M McCuaig, Tracy L Stockley, Patricia Shaw, Michael Fung-Kee-Fung, Alon D Altman, James Bentley, Marcus Q Bernardini, Beatrice Cormier, Hal Hirte, Katharina Kieser,[...]. J Med Genet 2018
18
33

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
33

Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
Jeanna M McCuaig, Alicia A Tone, Manjula Maganti, Tina Romagnuolo, Nicole Ricker, Jennifer Shuldiner, Gary Rodin, Tracy Stockley, Raymond H Kim, Marcus Q Bernardini. Gynecol Oncol 2019
5
33

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
879
33

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
281
33

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
33


Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.
Barbara M Norquist, Kathryn P Pennington, Kathy J Agnew, Maria I Harrell, Christopher C Pennil, Ming K Lee, Silvia Casadei, Anne M Thornton, Rochelle L Garcia, Tom Walsh,[...]. Gynecol Oncol 2013
20
33

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
42
33

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Pål Møller, Toni Seppälä, Inge Bernstein, Elke Holinski-Feder, Paola Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf Sijmons,[...]. Gut 2017
230
33

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
33

Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
84
33

Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
Thomas C Randall, Katrina Armstrong. Curr Treat Options Oncol 2016
18
33

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
33

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
82
33


Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
841
33

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
33
33

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.
Ettore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, Frederique Penault-Llorca, Marjolijn J L Ligtenberg, Susana Banerjee, Christian Singer, Eitan Friedman, Birgid Markiefka, Peter Schirmacher,[...]. Semin Oncol 2017
49
33

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
33

Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling.
Annabeth Høgh Petersen, Mads Malik Aagaard, Henriette Roed Nielsen, Karina Dahl Steffensen, Marianne Waldstrøm, Anders Bojesen. Eur J Hum Genet 2016
9
33

BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
Janice S Kwon, Anna V Tinker, Gillian E Hanley, Gary Pansegrau, Sophie Sun, Mark S Carey, Intan Schrader. Gynecol Oncol 2019
6
33

Projected estimates of cancer in Canada in 2020.
Darren R Brenner, Hannah K Weir, Alain A Demers, Larry F Ellison, Cheryl Louzado, Amanda Shaw, Donna Turner, Ryan R Woods, Leah M Smith. CMAJ 2020
72
33


Leiden Open Variation Database of the MUTYH gene.
Astrid A Out, Carli M J Tops, Maartje Nielsen, Marjan M Weiss, Ivonne J H M van Minderhout, Ivo F A C Fokkema, Marie-Pierre Buisine, Kathleen Claes, Chrystelle Colas, Riccardo Fodde,[...]. Hum Mutat 2010
55
33

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
60
33

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
665
33

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
132
33

Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
38
33

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
328
33

BRCA mutation in ovarian cancer: testing, implications and treatment considerations.
Robert T Neff, Leigha Senter, Ritu Salani. Ther Adv Med Oncol 2017
39
33

Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.
Yaser R Hussein, Jennifer A Ducie, Angela G Arnold, Noah D Kauff, Hebert A Vargas-Alvarez, Evis Sala, Douglas A Levine, Robert A Soslow. Am J Surg Pathol 2016
14
33

Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation.
Rachel Rosenthal, Henry Hoffmann, Pierre-Alain Clavien, Heiner C Bucher, Salome Dell-Kuster. World J Surg 2015
57
33

BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Marco Petrillo, Claudia Marchetti, Rossella De Leo, Angela Musella, Ettore Capoluongo, Ida Paris, Pierluigi Benedetti Panici, Giovanni Scambia, Anna Fagotti. Am J Obstet Gynecol 2017
34
33

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.
D J Gallagher, J A Konner, K M Bell-McGuinn, J Bhatia, P Sabbatini, C A Aghajanian, K Offit, R R Barakat, D R Spriggs, N D Kauff. Ann Oncol 2011
69
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.